Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.6740
+0.0040 (0.60%)
Apr 30, 2026, 12:51 PM CET
Isofol Medical AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
214.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 721.00K | -12.08M | -94.37% |
| Dec 31, 2022 | 12.80M | -9.61M | -42.89% |
| Dec 31, 2021 | 22.41M | -14.71M | -39.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sprint Bioscience AB | 167.39M |
| Xbrane Biopharma AB | 152.35M |
| Bio-Works Technologies AB | 63.11M |
| Elicera Therapeutics AB | 10.64M |
| Xintela AB | 2.28M |
| Alligator Bioscience AB | 839.00K |
| Diamyd Medical AB | 362.00K |
| Mendus AB | -1.44M |
Isofol Medical AB News
- 7 weeks ago - Isofol Medical AB Transcript: Stora Aktiedagarna 2026 - Transcripts
- 6 months ago - Isofol Medical AB Transcript: Investor Update - Transcripts
- 8 months ago - Isofol Medical AB Earnings Call Transcript: Q2 2025 - Transcripts
- 3 years ago - Isofol Medical AB Earnings Call Transcript: Q1 2023 - Transcripts
- 3 years ago - Isofol Medical AB Earnings Call Transcript: Q4 2022 - Transcripts
- 3 years ago - Isofol Medical AB Earnings Call Transcript: Q3 2022 - Transcripts
- 4 years ago - Isofol Medical AB Earnings Call Transcript: Q2 2022 - Transcripts
- 4 years ago - Isofol Medical AB Earnings Call Transcript: Q1 2022 - Transcripts